Remaining Licensed Products Sample Clauses

Remaining Licensed Products. In the event LICENSOR elects not to purchase remaining Licensed Products pursuant to the provision above, then LICENSEE shall have one hundred eighty (180) calendar days to sell the Licensed Products if the Agreement is expiring or is being terminated by the parties for reasons other than for LICENSEE’s material breach of the terms of the Agreement (the “Sell-Off Period”). Such sales shall be made in full conformance with the requirements of this Agreement. After the one hundred eighty (180) calendar day selling period, LICENSEE shall have the right to sell the Licensed Products only after the Trademarks and features embodying the IP Rights have been removed therefrom prior to sale, unless the parties agree otherwise in writing. In the event LICENSOR elects not to purchase remaining Licensed Products pursuant to the provision above, following LICENSOR’s termination of the Agreement due to LICENSEE’s material breach of a term of the Agreement, then LICENSEE shall have three (3) months to sell the Licensed Products (the “Breach Sell-Off Period”). Such sales shall be made in full conformance with the requirements of this Agreement. After the three (3) month selling period following termination of the Agreement due to material breach by LICENSEE, LICENSEE shall have the right to sell the Licensed Products only after the Trademarks and features embodying the IP Rights have been removed therefrom prior to sale, unless the parties agree otherwise in writing.
Sample 1
AutoNDA by SimpleDocs

Related to Remaining Licensed Products

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Territory The territorial limits of this Agreement shall be identical with those of the Reinsured Contracts.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Royalty Term Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired.

Time is Money Join Law Insider Premium to draft better contracts faster.